The goal of gene therapy for patients with hemophilia A is to safely impart long-term stable factor VIII expression that predictably ameliorates bleeding with the use of the lowest possible vector ...
Expression was determined using a validated immunohistochemistry (IHC) assay, 17 categorized on the basis of numerical scores, and then divided into equally sized quartiles. Interaction between ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback